Research Analysts’ Recent Ratings Changes for Cooper Companies (COO)

Cooper Companies (NASDAQ: COO) has recently received a number of price target changes and ratings updates:

• 6/21/2026 – Cooper Companies was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/13/2026 – Cooper Companies was downgraded by Wall Street Zen from “buy” to “hold”.
• 6/8/2026 – Cooper Companies was downgraded by Weiss Ratings from “hold (c-)” to “sell (d)”.
• 6/8/2026 – Cooper Companies had its price target lowered by BNP Paribas Exane from $95.00 to $92.00. They now have an “outperform” rating on the stock.
• 6/5/2026 – Cooper Companies had its “sector weight” rating reaffirmed by KeyCorp.
• 6/5/2026 – Cooper Companies had its “sell” rating reaffirmed by Wells Fargo & Company. They now have a $66.00 price target on the stock, down from $82.00.
• 6/5/2026 – Cooper Companies had its price target lowered by JPMorgan Chase & Co. from $80.00 to $71.00. They now have a “neutral” rating on the stock.
• 6/5/2026 – Cooper Companies had its price target lowered by Stifel Nicolaus from $95.00 to $85.00. They now have a “buy” rating on the stock.
• 6/5/2026 – Cooper Companies had its price target lowered by Robert W. Baird from $98.00 to $85.00. They now have an “outperform” rating on the stock.
• 6/5/2026 – Cooper Companies had its price target lowered by Needham & Company LLC from $101.00 to $86.00. They now have a “buy” rating on the stock.
• 6/4/2026 – Cooper Companies was given a new $85.00 price target by Mizuho. They now have an “outperform” rating on the stock.
• 6/1/2026 – Cooper Companies was given a new $86.00 price target by Piper Sandler. They now have an “overweight” rating on the stock.
• 5/28/2026 – Cooper Companies had its “neutral” rating reaffirmed by Citigroup Inc.. They now have a $69.00 price target on the stock, down from $80.00.
• 5/27/2026 – Cooper Companies was given a new $61.00 price target by The Goldman Sachs Group, Inc..

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.